Monitor for any conversion of this 13G to a 13D, which would signal activist intent. The accumulation of passive stakes by multiple large institutions (Prudential, Balyasny, Trails Edge) suggests growing institutional interest but no near-term catalyst.
Price Chart
Executive Summary
Prudential Financial Inc. disclosed a passive 11.2% stake in Neurogene Inc. via a Schedule 13G filed on October 7, 2026, as of September 30, 2026. The stake consists of 2,231,357 shares, held primarily through its subsidiary Jennison Associates LLC (2,229,082 shares). This is a new passive filing for Prudential, adding to a growing list of institutional holders in Neurogene alongside Balyasny Asset Management and Trails Edge Capital Partners.
Key Financial Metrics
Key Facts
- Prudential Financial Inc. disclosed a 11.2% beneficial ownership stake in Neurogene Inc.
- Total shares held: 2,231,357 as of September 30, 2026.
- Jennison Associates LLC holds 2,229,082 shares (11.15%); PGIM Quantitative Solutions LLC holds 2,275 shares (0.05%).
- Filed as a passive Schedule 13G under Rule 13d-1(b) — no intent to influence control.
- This is a new filing for Prudential; prior cross-filings show Balyasny Asset Management and Trails Edge Capital Partners also hold passive stakes.
Financial Impact
11.2% stake valued at approximately $5.6 million based on current market price (estimated from prior filings); no direct financial impact from the filing itself.
Risk Factors
- Passive 13G filing — no control intent; stake could be reduced without notice.
- Biotech (pharmaceutical preparations) sector risk; clinical-stage company with no approved products.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001137774-26-000205 |
| Document: 0001137774-26-000205-index.html | 0001137774-26-000205 |
| Document: 0001137774-26-000205.txt | 0001137774-26-000205 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | SC 13G | $25.87 | awaiting T+20 | — | $23.54 (−9.01%) |
Oct 6, 2026 20d ago | SC 13G | $25.45 | awaiting T+20 | — | $23.54 (−7.50%) |
Aug 11, 2026 10w ago | 8-K | $36.55 $37.88 | ▲ +3.64% | ▲ +4.70% | $23.54 (−35.60%) |
Jun 30, 2026 16w ago | 424B5 | $33.88 $33.66 | ▲ +0.65% | ▼ −1.54% | $23.54 (+30.52%) |
Jun 29, 2026 17w ago | 8-K | $32.28 $34.90 | ▲ +8.12% | ▲ +8.40% | $23.54 (−27.08%) |
Jun 8, 2026 20w ago | 8-K | $28.60 $32.56 | ▲ +13.85% | ▲ +12.21% | $23.54 (−17.69%) |
Apr 20, 2026 27w ago | 8-K | $27.74 $27.98 | ▲ +0.87% | ▼ −3.34% | $23.54 (−15.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers